The prognostic value of the triglyceride-glucose index in individuals with hypertension

Hypertension frequently coexists with metabolic abnormalities that contribute to cardiovascular risk. The triglyceride-glucose (TyG) index is a simple surrogate marker of insulin resistance that may also reflect early cardiometabolic and cardiovascular vulnerability. This narrative review examines the prognostic relevance of TyG for all-cause mortality, cardiovascular mortality, and fatal or non-fatal cardiovascular events in hypertension. PubMed, Embase, and the Cochrane Library were searched through 5 October 2026, without date or language restrictions. Evidence from primary hypertensive cohorts generally supports associations between higher TyG and adverse outcomes, although their magnitude and shape vary, with both linear and nonlinear patterns reported. Findings are most consistent among hypertensive patients with diabetes, whereas results from other high-risk settings and hypertension-specific subgroup analyses are more heterogeneous. Differences in TyG calculation, modeling, glycemic status, clinical settings, and overlapping cohorts complicate comparisons across studies. Overall, TyG may represent a readily available, low-cost marker of early cardiometabolic and cardiovascular vulnerability, beyond its role as a surrogate of insulin resistance, with potential to refine cardiovascular risk stratification in hypertension. Further prospective validation should establish its incremental predictive value beyond conventional cardiovascular risk factors and established risk scores.

Authors

Institutions

Publication Details

Journal
Future Cardiology
Published
2026-11-14
DOI
https://doi.org/10.1080/14796678.2026.2762672
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The prognostic value of the triglyceride-glucose index in individuals with hypertension

Lanfranco D’Elia, Ersilia La Fata, Vittorio Salvatore, Claudia Ciampa et al.
Future Cardiology
Diabetes, Cardiovascular Risks, and Lipoproteins
article

The prognostic value of the triglyceride-glucose index in individuals with hypertension

Lanfranco D’Elia, Ersilia La Fata, Vittorio Salvatore, Claudia Ciampa, Saverio Stranges, Ferruccio Galletti
article en

Abstract

Hypertension frequently coexists with metabolic abnormalities that contribute to cardiovascular risk. The triglyceride-glucose (TyG) index is a simple surrogate marker of insulin resistance that may also reflect early cardiometabolic and cardiovascular vulnerability. This narrative review examines the prognostic relevance of TyG for all-cause mortality, cardiovascular mortality, and fatal or non-fatal cardiovascular events in hypertension. PubMed, Embase, and the Cochrane Library were searched through 5 October 2026, without date or language restrictions. Evidence from primary hypertensive cohorts generally supports associations between higher TyG and adverse outcomes, although their magnitude and shape vary, with both linear and nonlinear patterns reported. Findings are most consistent among hypertensive patients with diabetes, whereas results from other high-risk settings and hypertension-specific subgroup analyses are more heterogeneous. Differences in TyG calculation, modeling, glycemic status, clinical settings, and overlapping cohorts complicate comparisons across studies. Overall, TyG may represent a readily available, low-cost marker of early cardiometabolic and cardiovascular vulnerability, beyond its role as a surrogate of insulin resistance, with potential to refine cardiovascular risk stratification in hypertension. Further prospective validation should establish its incremental predictive value beyond conventional cardiovascular risk factors and established risk scores.

Future Cardiology
Western University (CA), Ospedale Antonio Cardarelli (IT), Federico II University Hospital (IT), Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona (IT), University of Naples Federico II (IT)
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon